These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 17070624)
1. Viral vectored immunocontraception: screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector. Redwood AJ; Harvey NL; Lloyd M; Lawson MA; Hardy CM; Shellam GR Vaccine; 2007 Jan; 25(4):698-708. PubMed ID: 17070624 [TBL] [Abstract][Full Text] [Related]
2. Overcoming innate host resistance to vaccination: employing a genetically distinct strain of murine cytomegalovirus avoids vector-mediated resistance to virally vectored immunocontraception. Nikolovski S; Lloyd ML; Harvey N; Hardy CM; Shellam GR; Redwood AJ Vaccine; 2009 Aug; 27(38):5226-32. PubMed ID: 19591797 [TBL] [Abstract][Full Text] [Related]
3. Immunization with recombinant murine cytomegalovirus expressing murine zona pellucida 3 causes permanent infertility in BALB/c mice due to follicle depletion and ovulation failure. O'Leary S; Lloyd ML; Shellam GR; Robertson SA Biol Reprod; 2008 Nov; 79(5):849-60. PubMed ID: 18667753 [TBL] [Abstract][Full Text] [Related]
4. Promoter control over foreign antigen expression in a murine cytomegalovirus vaccine vector. Cunningham PT; Lloyd ML; Harvey NL; Williams E; Hardy CM; Redwood AJ; Lawson MA; Shellam GR Vaccine; 2010 Dec; 29(1):141-51. PubMed ID: 20338212 [TBL] [Abstract][Full Text] [Related]
5. Species-specificity of a murine immunocontraceptive utilising murine cytomegalovirus as a gene delivery vector. Smith LM; Lloyd ML; Harvey NL; Redwood AJ; Lawson MA; Shellam GR Vaccine; 2005 Apr; 23(23):2959-69. PubMed ID: 15811641 [TBL] [Abstract][Full Text] [Related]
6. Prior infection with murine cytomegalovirus (MCMV) limits the immunocontraceptive effects of an MCMV vector expressing the mouse zona-pellucida-3 protein. Gorman S; Lloyd ML; Smith LM; McWhorter AR; Lawson MA; Redwood AJ; Shellam GR Vaccine; 2008 Jul; 26(31):3860-9. PubMed ID: 18573574 [TBL] [Abstract][Full Text] [Related]
7. Development of mouse-specific contraceptive vaccines: infertility in mice immunized with peptide and polyepitope antigens. Hardy CM; Clydesdale G; Mobbs KJ Reproduction; 2004 Oct; 128(4):395-407. PubMed ID: 15454634 [TBL] [Abstract][Full Text] [Related]
8. Innate antiviral resistance influences the efficacy of a recombinant murine cytomegalovirus immunocontraceptive vaccine. Lloyd ML; Nikolovski S; Lawson MA; Shellam GR Vaccine; 2007 Jan; 25(4):679-90. PubMed ID: 17007971 [TBL] [Abstract][Full Text] [Related]
9. Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. Redwood AJ; Messerle M; Harvey NL; Hardy CM; Koszinowski UH; Lawson MA; Shellam GR J Virol; 2005 Mar; 79(5):2998-3008. PubMed ID: 15709020 [TBL] [Abstract][Full Text] [Related]
10. Current status of virally vectored immunocontraception for biological control of mice. Hardy CM Soc Reprod Fertil Suppl; 2007; 63():495-506. PubMed ID: 17566294 [TBL] [Abstract][Full Text] [Related]
11. Intranasal co-delivery with the mouse zona pellucida 3 and GM-CSF expressing constructs enhances humoral immune responses and contraception in mice. Ma X; Li J; Zhang F Scand J Immunol; 2012 Dec; 76(6):521-7. PubMed ID: 22924630 [TBL] [Abstract][Full Text] [Related]
12. The effects of GM-CSF and IL-5 as molecular adjuvants on immune responses and contraception induced by mZP3 DNA vaccination. Ma X; Kadir Z; Li J; Zhang F Am J Reprod Immunol; 2012 Dec; 68(6):476-85. PubMed ID: 22934542 [TBL] [Abstract][Full Text] [Related]
13. Immunocontraception in mice using repeated, multi-antigen peptides: immunization with purified recombinant antigens. Hardy CM; Beaton S; Hinds LA Mol Reprod Dev; 2008 Jan; 75(1):126-35. PubMed ID: 17474093 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the immunocontraceptive effect of a zona pellucida 3 peptide antigen in wild mice. Hardy CM; ten Have JF; Mobbs KJ; Hinds LA Reprod Fertil Dev; 2002; 14(3-4):151-5. PubMed ID: 12219936 [TBL] [Abstract][Full Text] [Related]
15. Strategies for designing an immunocontraceptive vaccine based on zona pellucida synthetic peptides and recombinant antigen. Kaul R; Afzalpurkar A; Gupta SK J Reprod Fertil Suppl; 1996; 50():127-34. PubMed ID: 8984175 [TBL] [Abstract][Full Text] [Related]
17. Contraceptive responses of mice immunized with purified recombinant mouse zona pellucida subunit 3 (mZP3) proteins. Hardy CM; ten Have JF; Pekin J; Beaton S; Jackson RJ; Clydesdale G Reproduction; 2003 Jul; 126(1):49-59. PubMed ID: 12814347 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of antibodies against a chimeric synthetic peptide encompassing epitopes of bonnet monkey (Macaca radiata) zona pellucida-1 and zona pellucida-3 glycoproteins to inhibit in vitro human sperm-egg binding. Sivapurapu N; Hasegawa A; Gahlay GK; Koyama K; Gupta SK Mol Reprod Dev; 2005 Mar; 70(3):247-54. PubMed ID: 15625695 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of zona pellucida antigens as potential candidates for immunocontraception. Paterson M; Wilson MR; van Duin M; Aitken RJ J Reprod Fertil Suppl; 1996; 50():175-82. PubMed ID: 8984181 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and contraceptive potential of three infertility-relevant zona pellucida 2 epitopes in the marsupial brushtail possum (Trichosurus vulpecula). Duckworth JA; Wilson K; Cui X; Molinia FC; Cowan PE Reproduction; 2007 Jan; 133(1):177-86. PubMed ID: 17244744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]